A non-governmental organisation has published guidance that it says will give companies a "head-start" in meeting the challenges of complying with the provisions of the UK Bribery Act, which comes into force in April 2011 1-3 . Transparency ...
The US Food and Drug Administration should, as far as possible, rely on existing standards to achieve the objectives of its "home-use" initiative, which aims to assure the safe use of medical devices in patients' homes, says medtech industry ...
The US Supreme Court has agreed to review Matrixx Initiatives Inc v Siracusano, a case that has the potential to determine which adverse event reports drug and medical device companies must disclose to shareholders to avoid securities suits 1 . ...
The US Food and Drug Administration is developing guidance for contact lens manufacturers on potential labelling improvements for contact lens care products 1 . Also, the FDA has developed a new video on contact lens safety for consumers that ...
Health Canada , in response to reports of inaccurate temperature readings from infrared thermometers, is asking manufacturers to strengthen their product labelling by including extra information in the directions for use 1 . Effective as of May 21, ...
The Australian government has published two consultation papers with the aim of setting up a more streamlined, efficient and transparent approach to the self-regulation of medicines and medical devices promotion to healthcare professionals in the ...
As doctors in the US brace themselves for the 30 million new patients that the new healthcare reform law promises to channel into the system, a key mechanism for advancing their medical knowledge and performance is facing tumultuous times. Certified ...
The UK Bribery Act, which was signed into law earlier this year, will come into force in April 2011, the Ministry of Justice has announced 1 ,2 . Its implementation is expected to pave the way for fairer practice by encouraging companies to adopt ...
